Quick Answer
Picard Medical, Inc. reported R&D Expense of $3.05 million for fiscal year 2025.
Picard Medical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $3.05M | -9.8% |
| 2024 | $3.38M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $951.0K | -1.0% | +28.0% |
| June 30, 2025 | $743.0K | -21.0% | -22.7% |
| September 30, 2024 | $961.0K | — | +2.2% |
| June 30, 2024 | $940.0K | — | — |
- Picard Medical, Inc. showed a decrease of -9.8% in R&D Expense compared to the prior fiscal year.
- Over the 2024–2025 period, Picard Medical, Inc.’s r&d expense has declined by 9.8% (from $3.38 million to $3.05 million).
- The most recent figure is from Picard Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: